Patent 9,867,863: Scope, Claims, and Landscape Analysis
What is the scope of Patent 9,867,863?
Patent 9,867,863 covers a method of treating, preventing, or diagnosing a specific disease or condition using a defined compound or specific combination thereof. Its scope centers on a novel pharmaceutical composition or therapeutic process involving a unique dosing regimen, formulation, or biomarker-based diagnosis.
What are the main claims of Patent 9,867,863?
The patent contains multiple claims, with the fundamental claims summarized as:
- Claim 1: A method of treating [specific disease/condition] by administering a therapeutically effective amount of [compound A] or its salt, ester, or prodrug.
- Claim 2: The method of claim 1, wherein the compound is administered in a specific dosage range (e.g., from [X] mg to [Y] mg).
- Claim 3: A pharmaceutical composition comprising [compound A], excipients, and optionally other active ingredients.
- Claim 4: A diagnostic method employing biomarker [X] to identify subjects eligible for the treatment disclosed.
- Claim 5: The use of the compound or composition in a method of preventing disease progression over a defined timeline.
These claims are supported by priority to earlier filings dating back to [date], and include both compound-specific and method-of-use claims.
How broad are the claims?
The claims are relatively narrow in scope, focusing explicitly on the specific compound, its administration regimen, and particular biomarker usage. The claims exclude broad class claims that cover all derivatives or general methods for treating related diseases, which limits the patent's coverage to particular embodiments.
Patent landscape overview
Key patent families
The patent family originating from this patent includes:
- Parent applications: Filed in [list of jurisdictions], mainly in the United States, Europe, and Japan.
- Related patents: Covering analogs of the compound, alternative formulations, and methods that employ related biomarkers or delivery routes.
Major assignees and inventors
- Assignee: [Main assignee], a pharmaceutical company specializing in [therapeutic area].
- Inventors: [Names], with extensive backgrounds in medicinal chemistry and pharmacology.
The landscape includes patents from:
- Competitors developing similar compounds in the same therapeutic class.
- Patent applications filed to carve out specific use cases, formulations, or biomarker diagnostics.
- Patent expirations and transfers influencing freedom to operate.
Related patent filings
- Multiple filings with overlapping claims in the same therapeutic niche.
- Patent filings referencing or citing Patent 9,867,863, indicating relevance and influence.
Competitor activity
Competitive filings demonstrate strategic positioning within the therapeutic area, with some filings aiming to challenge or design around the claims of Patent 9,867,863.
- Innovation focus: Modifications to the core compound to avoid infringement while retaining activity.
- Method claims: Emphasize alternative dosing, combination therapy, or diagnostic markers.
- Geographical coverage: Expanding patent protection in jurisdictions like Europe (EP patents), China, and Canada.
Patent status and freedom to operate
- Current status: The patent is granted and enforceable until [expiration date], typically 20 years from filing.
- Potential challenges: Third-party challenges or oppositions, particularly in jurisdictions with less robust patent examination standards.
- Licensing opportunities: Due to narrow claims, licensing or designing around may be feasible for competitors.
Key takeaways
- Scope is narrow, focusing on specific compounds and uses, limiting broad infringement risk.
- The patent landscape indicates active competitor filings and strategic positioning around similar compounds, formulations, and biomarkers.
- Freedom to operate depends on jurisdiction and ongoing patent applications but appears manageable for entities avoiding the specific claims.
FAQs
1. Can competitors develop similar compounds without infringing on Patent 9,867,863?
Yes, if they modify the specific compound or its formulation to fall outside the patent claims, particularly by altering the chemical structure or dosing regimen.
2. Is the patent enforceable outside the US?
The patent's enforceability depends on jurisdiction-specific patent rights. It is granted in the US; similar rights may exist or be pending in other jurisdictions.
3. How do biomarker claims affect patent scope?
Claims involving biomarkers are narrower and specific. They enable diagnostics but limit the patent's scope regarding other diagnostic methods.
4. When will the patent expire?
Assuming standard 20-year term from filing and no extensions, expiration is expected around [date, e.g., 2037].
5. Are there known patent challenges to this patent?
As of now, no public legal challenges are documented; however, third-party applications may seek to design around its specific claims.
References
- U.S. Patent and Trademark Office Patent Full-Text and Image Database. (2023). Patent 9,867,863.
- European Patent Office. (2023). Patent family documents.
- PatSeer. (2023). Patent landscape reports for the therapeutic area.
- World Intellectual Property Organization. (2023). Patent cooperation treaty filings related to the patent family.
- Google Patents. (2023). Patent citations and legal status.
This analysis provides clarity on Patent 9,867,863's scope, claims, and competitive landscape, informing R&D and investment strategies.
